Global Technetium-Labeled Tracer Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Technetium-Labeled Tracer Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Technetium-Labeled Tracer Market
Global Technetium-Labeled Tracer market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Technetium-Labeled Tracer industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Technetium-Labeled Tracer key companies include Cardinal Health, GE Healthcare, Curium Pharma, Bracco Imaging, SIEMENS, Lantheus, China Isotope & Radiation Corporation, Yantai Dongcheng and Beijing Zhibo Hi-Tech Biotechnology Co., Ltd., etc. Cardinal Health, GE Healthcare, Curium Pharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Technetium-Labeled Tracer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Technetium-Labeled Tracer market and estimated to attract more attentions from industry insiders and investors.
Technetium-Labeled Tracer can be divided into 99mTc-PYP, 99mTc-DPD and 99mTc-HMDP,, etc. 99mTc-PYP is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Technetium-Labeled Tracer is widely used in various fields, such as Bone Imaging, Thyroid Imaging, Brain Imaging and Salivary Gland Imaging, etc. Bone Imaging provides greatest supports to the Technetium-Labeled Tracer industry development. In 2022, global % revenue of Technetium-Labeled Tracer went into Bone Imaging filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Technetium-Labeled Tracer market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Technetium-Labeled Tracer market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Cardinal Health
GE Healthcare
Curium Pharma
Bracco Imaging
SIEMENS
Lantheus
China Isotope & Radiation Corporation
Yantai Dongcheng
Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
Foshan Rui Diao Pharmaceutical
Segment by Type
99mTc-PYP
99mTc-DPD
99mTc-HMDP
Bone Imaging
Thyroid Imaging
Brain Imaging
Salivary Gland Imaging
Heterotopic Gastric Mucosal Imaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Technetium-Labeled Tracer introduction, etc. Technetium-Labeled Tracer Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Technetium-Labeled Tracer
Chapter 13Methodology and Data Sources adopted by MRAResearch
Global Technetium-Labeled Tracer market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Technetium-Labeled Tracer industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Technetium-Labeled Tracer key companies include Cardinal Health, GE Healthcare, Curium Pharma, Bracco Imaging, SIEMENS, Lantheus, China Isotope & Radiation Corporation, Yantai Dongcheng and Beijing Zhibo Hi-Tech Biotechnology Co., Ltd., etc. Cardinal Health, GE Healthcare, Curium Pharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Technetium-Labeled Tracer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Technetium-Labeled Tracer market and estimated to attract more attentions from industry insiders and investors.
Technetium-Labeled Tracer can be divided into 99mTc-PYP, 99mTc-DPD and 99mTc-HMDP,, etc. 99mTc-PYP is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Technetium-Labeled Tracer is widely used in various fields, such as Bone Imaging, Thyroid Imaging, Brain Imaging and Salivary Gland Imaging, etc. Bone Imaging provides greatest supports to the Technetium-Labeled Tracer industry development. In 2022, global % revenue of Technetium-Labeled Tracer went into Bone Imaging filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Technetium-Labeled Tracer market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Technetium-Labeled Tracer market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Cardinal Health
GE Healthcare
Curium Pharma
Bracco Imaging
SIEMENS
Lantheus
China Isotope & Radiation Corporation
Yantai Dongcheng
Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
Foshan Rui Diao Pharmaceutical
Segment by Type
99mTc-PYP
99mTc-DPD
99mTc-HMDP
Segment by Application
Bone Imaging
Thyroid Imaging
Brain Imaging
Salivary Gland Imaging
Heterotopic Gastric Mucosal Imaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Technetium-Labeled Tracer introduction, etc. Technetium-Labeled Tracer Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Technetium-Labeled Tracer
Chapter 13Methodology and Data Sources adopted by MRAResearch